Find your path to Guy
90 people in our graph share verified history with Guy — schools, employers, funds. One of them is your warm intro.
Greg RaizunlockedGuy: together at Tufts University (1996–1998)
×4Guy: together at Tufts University
Guy: together at Curevo Vaccine
×2Guy: together at London School of Hygiene and Tropical Medicine, U. of London
CMO at Curevo Vaccine
Intro paths
→
In turn, Guy can intro founders to Curevo Vaccine's investors below.
Curevo Vaccine's investors · 7
Experience
- Curevo VaccineChief Medical Officercurrent2023 — presentUnited States
- Enanta PharmaceuticalsExecutive Director, Clinical Development (Infectious Diseases)2020 — 2023Watertown, MA
- TakedaSenior Medical Director, Clinical Development2018 — 2020Cambridge, Massachusetts, United States
- The Janssen Pharmaceutical Companies of Johnson & JohnsonMedical Leader - Lumicitabine (JNJ-64041575, ALS-008176)2016 — 2018Titusville, NJ
- The Janssen Pharmaceutical Companies of Johnson & JohnsonGlobal Medical Affairs Leader (Darunavir, Rilpivirine, Simeprevir)2009 — 2016Titusville, NJ
- The Janssen Pharmaceutical Companies of Johnson & JohnsonMedical Director (Darunavir)2007 — 2010Titusville, NJ
- AbbottSenior Clinical Science Manager - Virology (HIV)2005 — 2007Abbott Park, IL
- University of IowaAssistant Clinical Professor Medicine2002 — 2005Des Moines, Iowa Area
Skills & more
Clinical TrialsClinical DevelopmentInfectious DiseasesPharmaceutical IndustryClinical ResearchMedical AffairsProduct LaunchMedicine
Languages English · French · Spanish
From Guy's professional profile.
Frequently asked questions
- Who is Guy De La Rosa?
- CMO at Curevo Vaccine
- Where does Guy De La Rosa work?
- Guy De La Rosa is CMO at Curevo Vaccine.
- Where did Guy De La Rosa go to school?
- Guy De La Rosa studied at UTHealth Houston (HIV Fellowship); London School of Hygiene and Tropical Medicine, U. of London (Degree on Tropical Medicine & Hygiene); UTHealth Houston (Fellowship in Infectious Diseases).
Same school
Also attended UTHealth Houston12
Marsha HartmanExecutives in Residence at GENERAL INCEPTIONAmanda de la GarzaPartner at Bios PartnersJohn PowderlyPresident & CEO at BioCyticsHimanshu BhatiaExecutive Officer, Director at RICOVRDeena BrecherChief Nursing Officer at MednitionJason TerrellChief Medical Officer at Volitionrx
+ 6 more
Also attended London School of Hygiene and Tropical Medicine, U. of London21
Miguel ForteAdvisor at Delin VenturesCraig RitchieAlzheimer's Moonshot Impact Board at StartUp HealthLiz GrubinInvestment Principal at Mulago FoundationDr. Eric HoskinsPartner, Healthcare Innovation at Maverix Private EquityKemi TesfazghiGates Foundation at i3 — Investing in Innovation AfricaMonique SmithInvestor at Rock Health Capital
+ 15 more
Also attended Tufts University375
Roger KrakoffGeneral Partner at Monta Vista CapitalMatt GersonInvestor at RevolutionAlex MorganInvestor at Khosla VenturesNiko CiminelliInvestor at Khosla VenturesClay BergerInvestor at IVP (Institutional Venture Partners)Kathryn ReddyPrincipal at .406 Ventures
+ 369 more
Shared employers
Also worked at Curevo Vaccine5
Also worked at Enanta Pharmaceuticals6
Dr. Jens EcksteinAdvisor at Apollo Health VenturesAxel BolteFounder at Inozyme PharmaStephen HuangSenior Vice President, Head of Clinical Development at EthyrealbioMatthew D. RonsheimChief Operating Officer at Xenon PharmaTara L. KiefferChief Product Strategy Officer at Enanta PharmaceuticalsBrendan LuuChief Business Officer at Enanta Pharmaceuticals
Also worked at Takeda77
Rebecca RedfieldSenior Associate at .406 VenturesAtsushi ShimadaSenior Principal at AN Venture PartnersDai HataAssociate at AN Venture PartnersJulie KimRepresentative Director – President and CEO at Takeda VenturesAkiko AmakawaCEO Chief of Staff at Takeda VenturesAsuka MiyabashiraPresident, Japan Pharma Business Unit at Takeda Ventures
+ 71 more
Also worked at The Janssen Pharmaceutical Companies of Johnson & Johnson94
Patrick LoerchBio Advisor at Amplify PartnersUmut EserVenture Partner at Magnetic VenturesLance BermanVenture Partner at Ysios CapitalJuan CuevaDirector, Early Innovation Partnering at Johnson & Johnson at Joyance PartnersPatrick ForsterInvestment Analyst at The Spartan GroupMichael KalosInvestor at 82VS
+ 88 more







































)



